The Bench of the National Company Law Tribunal (NCLT) here has ordered the liquidation of debt-ridden pharmaceutical company Sterling Biotech. This is a setback for its lenders. They were hoping they could withdraw the...
NCLT refers Sterling Biotech for liquidation
The dedicated bankruptcy court has rejected an application from the Sterling Biotech lenders to withdraw their insolvency resolution petition. The lenders, led by Andhra BankNSE 1.67 %, had sought the tribunal’s...
Madison Pacific opposes withdrawal of Sterling Biotech bankruptcy case
Lenders of Sterling Biotech were caught off guard when bondholders’ trustee Madison Pacific Trust Ltd challenged the withdrawal of bankruptcy proceedings initiated by banks on Tuesday saying it held over 10% voting...
NCLT rebukes Sterling Biotech resolution professional, demands explanation
The National Company Law Tribunal (NCLT) reprimanded the resolution professional of Sterling Biotech for failing to discharge his duties and has asked him to submit an explanation as to why he didn’t opt for liquidation...
CCI to hold off Monsanto probe for now
The Competition Commission of India will hold back for now a probe into alleged anti-competition trade practices of the Indian arm of the agri-business giant MonsantoNSE -0.16 %. The self-imposed embargo will continue...
NCLT sees violation of Sec 29(A) in Sterling Biotech case
The National Company Law Tribunal (NCLT) in the Sterling Biotech case for the second time has questioned the motive of lenders, led by Andhra Bank to withdraw their bankruptcy application and to choose a one-time...
NCLT reserves order in Sterling Biotech over settlement issue
Attempt to withdraw the insolvency proceedings against Sterling Biotech by committee of creditors did not materialize and the National Company Law Tribunal reserved its order in the matter and listed the matter for...
NCLT seeks views on Sterling Biotech promoters’ offer
The National Company Law Tribunal (NCLT) has directed the government, regulators, and investigation agencies to clear their stand before the dedicated bankruptcy court decides on the legality of the one-time settlement...
NCLT questions Sterling Biotech lenders on accepting deal from promoters
The National Company Law Tribunal (NCLT) asked lenders of Sterling Biotech how they had accepted the one-time settlement (OTS) offer from the promoters of the bankrupt firm. The NCLT also plans to write to central...
BioNTech hires banks for IPO worth up to $800 million: sources
BioNTech, Europe’s largest unlisted biotech firm by staff numbers, has hired banks to prepare for an initial public offering (IPO) worth as much as $800 million as early as this year, people familiar with the plan told...
Biotech startup Gossamer defies U.S. shutdown with risky IPO move
Gossamer Bio Inc said on Wednesday it has tweaked its initial public offering (IPO) so it can proceed despite a U.S. government shutdown that has frozen stock market debuts, an extraordinary move that the biotechnology...
HC dismisses Monsanto plea against CCI probe of directors
In a setback to US biotechnology major MonsantoNSE 0.29 %, the Delhi High Court on Tuesday dismissed its plea to stop the Competition Commission from probing its top officials’ role in a case related to alleged...
